TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling

BACKGROUND: Drug resistance limits the treatment effect of cisplatin-based chemotherapy in head and neck squamous cell carcinoma (HNSCC), and the underlying mechanism is not fully understood. The aim of this study was to explore the cause of cisplatin resistance in HNSCC. METHODS: We performed survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Teng, Yang, Yuemei, Chen, Zhihong, Wang, Jinsong, Wang, Xiaolei, Zheng, Yang, Wang, Chao, Wang, Yachen, Zhu, Zaiou, Ding, Xu, Zhou, Junbo, Li, Gang, Zhang, Hongchuang, Zhang, Wei, Wu, Yunong, Song, Xiaomeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391982/
https://www.ncbi.nlm.nih.gov/pubmed/37525222
http://dx.doi.org/10.1186/s13046-023-02775-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391982/
https://www.ncbi.nlm.nih.gov/pubmed/37525222
http://dx.doi.org/10.1186/s13046-023-02775-1

Ejemplares similares